CL2011002437A1 -
Quinoxaline derived compounds; pharmaceutical composition that includes them; process of preparation of the composition and its use in the treatment of tumor disorders. pct national phase.
- Google Patents
Quinoxaline derived compounds; pharmaceutical composition that includes them; process of preparation of the composition and its use in the treatment of tumor disorders. pct national phase.
Emmanuel Czach Michael Claus Eckhard Polymeropoulos
Original Assignee
Aeterna Zentaris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filedlitigationCriticalhttps://patents.darts-ip.com/?family=66326279&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2011002437(A1)"Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from EP09157141Aexternal-prioritypatent/EP2241557A1/en
Application filed by Aeterna Zentaris GmbhfiledCriticalAeterna Zentaris Gmbh
Publication of CL2011002437A1publicationCriticalpatent/CL2011002437A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Compuestos derivados de quinoxalina; composición farmacéutica que los comprende; procedimiento para preparar dicha composición y uso en el tratamiento de trastornos tumorales.Quinoxaline derived compounds; pharmaceutical composition comprising them; procedure for preparing said composition and use in the treatment of tumor disorders.
CL2011002437A2009-04-022011-09-30
Quinoxaline derived compounds; pharmaceutical composition that includes them; process of preparation of the composition and its use in the treatment of tumor disorders. pct national phase.
CL2011002437A1
(en)
Quinoxaline derived compounds; pharmaceutical composition that includes them; process of preparation of the composition and its use in the treatment of tumor disorders. pct national phase.
Compounds derived from substituted pyrrolidine-2-carboxamides; mdm2-p53 interaction inhibitors; pharmaceutical composition; and its use for the treatment of cancer, particularly solid tumors.
Compounds derived from benzothienyl-pyrrolotriazine, such as protein tyrosine kinase inhibitors; preparation process of said compounds; pharmaceutical composition that includes them; and its use for the treatment and / or prevention of cancer and tumor diseases.
"Substituted indazole-derived compounds, modulators of protein kinase activity; process of obtaining them; in vitro method to inhibit protein kinases; pharmaceutical composition and combination comprising them; and its use in the treatment of cancer "pct
Alkylated piperazine derivative compounds; pharmaceutical composition that includes them; process to prepare the pharmaceutical composition; kit and use in the treatment of immune disorders, cancer, cardiovascular diseases, inflammation, among others.
Compounds derived from amino substituted imidazopyridazines, kinase inhibitors, mknk2; Preparation method; intermediary compounds and their use; pharmaceutical composition; pharmaceutical combination; and its use for the treatment of cancer.
Tricyclic compounds that inhibit the kinase pi3 (pi3k); pharmaceutical composition that includes them; method to treat cancer; and its use for the treatment of cancer.
Compounds derived from 2-oxo-piperidine and 1,1-dioxide-thiazine, mdm2 inhibitors; pharmaceutical composition that includes them; and its use for the treatment of cancer.
Compounds derived from substituted benzothiene-pyridines, hiv replication inhibitors; pharmaceutical composition that includes them; pharmaceutical combination; pharmaceutical kit; and its use for the treatment of hiv.
Phenoxy-benzyl-carbamoyl derived compounds; pharmaceutical composition; process for preparing the pharmaceutical composition; and its use in the treatment of pain.
Compounds derived from azaquinolin-carboxamide, such as p70s6k inhibitors; its manufacturing method; pharmaceutical composition that includes them; and its use for the prophylactic or therapeutic treatment of hyperproliferative disorders, cancer, diabetic retinopathy, pain, eczema and age-related macular degeneration, among other diseases.